Location of Repository

Sleep in care homes

By Adam Gordon and John R.F. Gladman

Abstract

Sleep problems in older adults are common and disturbance in sleep is associated with increased mortality. These problems are more pronounced in the care home population because of institutional factors and a high prevalence of frailty and comorbidity. This article reviews the randomized controlled trials undertaken to address sleep problems in care homes. These suggest that standalone therapies – oral melatonin and light therapy – have no effect on sleep but that combination treatments – physical exercise plus sleep hygiene, physical exercise plus sleep hygiene plus light and melatonin plus light – may have positive effects. These effects are more marked for daytime arousal than nocturnal sleep. Practical considerations for care homes are how to maximise light exposure, incorporate exercise into daily routines and minimize night-time disruption for residents. Trials undertaken so far are compromised by small sample size and inappropriate randomization strategies and further research is therefore required

Publisher: Cambridge University Press
OAI identifier: oai:eprints.nottingham.ac.uk:1330
Provided by: Nottingham ePrints

Suggested articles

Preview

Citations

  1. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
  2. A multicomponent nonpharmacological intervention improves activity rhythms among nursing home residents with disrupted sleep/wake patterns. doi
  3. (2004). A national census of care home residents. Age Ageing. doi
  4. (1999). Are age differences in sleep due to phase differences in the output of the circadian timing system? Chronobiol Int.
  5. Benzodiazepines and the risk of falls in nursing home residents.
  6. (1995). Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiol Aging.
  7. Circadian phase resetting in older people by ocular bright light exposure.
  8. (1998). Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med.
  9. controlled trial of a nonpharmacological intervention to improve abnormal sleep/wake patterns in nursing home residents. doi
  10. (2000). Department of Health. Care Standards Act
  11. (2009). Diagnosis and Treatment of Sleep Disorders in Older Adults. Focus. doi
  12. Do plasma melatonin concentrations decline with age?
  13. Does physical activity improve sleep in impaired nursing home residents?
  14. Effect of Light Treatment on Sleep and Circadian Rhythms in Demented Nursing Home Patients.
  15. Effect of morning bright light treatment for restactivity disruption in institutionalized patients with severe Alzheimer's disease. Int Psychogeriatr. doi
  16. (1987). Evaluation of temazepam and diphenhydramine as hypnotics in a nursing-home population. Ann Pharmacother.
  17. Evidence-based recommendations for the assessment and management of sleep disorders in older persons.
  18. Exercise and sleep. Sleep Medicine Reviews. doi
  19. Exposure to light in healthy elderly subjects and alzheimer's patients.
  20. Factors affecting survival of elderly nursing home residents.
  21. Factors associated with incidence and persistence of symptoms of disturbed sleep in an elderly cohort: the Cardiovascular Health Study. doi
  22. Functional Incidental Training, mobility performance, and incontinence care with nursing home residents.
  23. Illumination levels in nursing home patients: effects on sleep and activity rhythms.
  24. (1994). Low illumination experienced by San Diego adults: Association with atypical depressive symptoms. Biological Psychiatry.
  25. Melatonin and bright-light treatment for restactivity disruption in institutionalized patients with Alzheimer's disease.
  26. Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study.
  27. Melatonin rhythmicity: effect of age and Alzheimer's disease. Experimental Gerontology.
  28. (1997). Nursing Homes in 10 Nations: A Comparison Between Countries and Settings. Age Ageing.
  29. (2003). Parkinson's disease and sleep. Sleep Med Rev. doi
  30. Physical Activity Levels of Ambulatory Nursing Home Residents.
  31. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. doi
  32. Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians.
  33. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.
  34. (2005). Sedative hypnotics in older people with insomnia: meta-analysis of risks and
  35. Sleep complaints among elderly persons: an epidemiologic study of three communities.
  36. (1990). Sleep disturbances in patients with mild-stage Alzheimer's disease. doi
  37. (1989). Sleep Fragmentation in Patients From a Nursing Home. Journal of Gerontology.
  38. (1993). Sleep in normal aging and dementia.
  39. Sleep Patterns and Mortality among Elderly Patients in a Geriatric Hospital.
  40. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64-99 years.
  41. (1991). Sleep-disordered breathing in communitydwelling elderly.
  42. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent.
  43. (1996). The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents[ast]. Clin Pharmacol Ther.
  44. (1998). The nighttime environment and incontinence care practices in nursing homes.
  45. The nighttime environment, incontinence care, and sleep disruption in nursing homes.
  46. (1985). The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. doi
  47. The use of melatonin in Alzheimer's disease.
  48. Use of wrist activity for monitoring sleep/wake in demented nursing-home patients.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.